Evidence map›Paper›PMID 27648080›Full record

ArticleJournal of environmental and public health2016

Identifying the Prognosis Factors in Death after Liver Transplantation via Adaptive LASSO in Iran.

Hadi Raeisi Shahraki, Saeedeh Pourahmad, Seyyed Mohammad Taghi Ayatollahi

Abstract read
In one paragraph

Article in Journal of environmental and public health, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Classification of Bladder Cancer Patients via Penalized Linear Discriminant AnalysisAsian Pacific journal of cancer prevention : APJCP · 2017
    Article
  5. BioMed research international · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Hadi Raeisi ShahrakiDepartment of Biostatistics, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.ORCID 0000-0003-3071-5587
Saeedeh PourahmadDepartment of Biostatistics, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.
Seyyed Mohammad Taghi AyatollahiDepartment of Biostatistics, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.ORCID 0000-0003-0198-5975

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Despite the widespread use of liver transplantation as a routine therapy in liver diseases, the effective factors on its outcomes are still controversial. This study attempted to identify the most effective factors on death after liver transplantation. For this purpose, modified least absolute shrinkage and selection operator (LASSO), called Adaptive LASSO, was utilized. One of the best advantages of this method is considering high number of factors. Therefore, in a historical cohort study from 2008 to 2013, the clinical findings of 680 patients undergoing liver transplant surgery were considered. Ridge and Adaptive LASSO regression methods were then implemented to identify the most effective factors on death. To compare the performance of these two models, receiver operating characteristic (ROC) curve was used. According to the results, 12 factors in Ridge regression and 9 ones in Adaptive LASSO regression were significant. The area under the ROC curve (AUC) of Adaptive LASSO was equal to 89% (95% CI: 86%-91%), which was significantly greater than Ridge regression (64%, 95% CI: 61%-68%) (p < 0.001). As a conclusion, the significant factors and the performance criteria revealed the superiority of Adaptive LASSO method as a penalized model versus traditional regression model in the present study.

Indexed as

Cohort StudiesHumansIranLiver TransplantationModels, TheoreticalPostoperative ComplicationsPrognosisRegression AnalysisRetrospective StudiesROC Curve

Identifiers

PMID27648080
PMCPMC5014976

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.